XML 35 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:
 9 Months Ended
Dec. 31, 2011
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:  
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:

2.             EARNINGS PER SHARE AND STOCKHOLDERS’ EQUITY:

 

Earnings Per Share

 

A reconciliation of the numerator and denominator of basic and diluted earnings per share is shown below (in thousands, except per share amounts):

 

 

 

For the quarter ended
December 31

 

For the nine months ended
December 31

 

 

 

2011

 

2010

 

2011

 

2010

 

Basic earnings per share:

 

 

 

 

 

 

 

 

 

Net earnings from continuing operations

 

$

1,837

 

$

19,973

 

$

22,775

 

$

39,856

 

Net earnings from discontinued operations

 

814

 

441

 

2,868

 

2,691

 

Net earnings

 

$

2,651

 

$

20,414

 

$

25,643

 

$

42,547

 

Net loss attributable to noncontrolling interest

 

(5,279

)

(409

)

(5,554

)

(1,362

)

Net earnings attributable to Acxiom

 

$

7,930

 

$

20,823

 

$

31,197

 

$

43,909

 

 

 

 

 

 

 

 

 

 

 

Basic weighted-average shares outstanding

 

78,189

 

80,233

 

80,039

 

80,007

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share:

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.02

 

$

0.25

 

$

0.28

 

$

0.50

 

Discontinued operations

 

$

0.01

 

$

0.01

 

$

0.04

 

$

0.03

 

Net earnings

 

$

0.03

 

$

0.25

 

$

0.32

 

$

0.53

 

Net loss attributable to noncontrolling interest

 

$

(0.07

)

$

(0.01

)

$

(0.07

)

$

(0.02

)

Net earnings attributable to Acxiom

 

$

0.10

 

$

0.26

 

$

0.39

 

$

0.55

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share:

 

 

 

 

 

 

 

 

 

Net earnings from continuing operations

 

$

1,837

 

$

19,973

 

$

22,775

 

$

39,856

 

Net earnings from discontinued operations

 

814

 

441

 

2,868

 

2,691

 

Net earnings

 

$

2,651

 

$

20,414

 

$

25,643

 

$

42,547

 

Net loss attributable to noncontrolling interest

 

(5,279

)

(409

)

(5,554

)

(1,362

)

Net earnings attributable to Acxiom

 

$

7,930

 

$

20,823

 

$

31,197

 

$

43,909

 

 

 

 

 

 

 

 

 

 

 

Basic weighted-average shares outstanding

 

78,189

 

80,233

 

80,039

 

80,007

 

 

 

 

 

 

 

 

 

 

 

Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method

 

831

 

1,865

 

838

 

1,606

 

 

 

 

 

 

 

 

 

 

 

Diluted weighted-average shares outstanding

 

79,020

 

82,098

 

80,877

 

81,613

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share:

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.02

 

$

0.24

 

$

0.28

 

$

0.49

 

Discontinued operations

 

$

0.01

 

$

0.01

 

$

0.04

 

$

0.03

 

Net earnings

 

$

0.03

 

$

0.25

 

$

0.32

 

$

0.52

 

Net loss attributable to noncontrolling interest

 

$

(0.07

)

$

0.00

 

$

(0.07

)

$

(0.02

)

Net earnings attributable to Acxiom

 

$

0.10

 

$

0.25

 

$

0.39

 

$

0.54

 

 

Some earnings per share amounts may not add due to rounding.

 

As of December 31, 2011, the Company had options and warrants outstanding providing for the purchase of approximately 9.9 million shares of common stock together with restricted stock units relating to 1.6 million shares of stock. Options, warrants and restricted stock units that were outstanding during the periods presented, but were not included in the computation of diluted earnings per share because the effect was antidilutive are shown below (in thousands, except per share amounts):

 

 

 

For the quarter ended
December 31

 

For the nine months ended
December 31

 

 

 

2011

 

2010

 

2011

 

2010

 

Number of shares outstanding under options, warrants and restricted stock units

 

9,515

 

5,647

 

9,438

 

5,969

 

Range of exercise prices for options and warrants

 

$12.25-$62.06

 

$17.76-$62.06

 

$13.14-$62.06

 

$16.71-$75.55

 

 

Stockholders’ Equity

 

On August 29, 2011, the board of directors adopted a common stock repurchase program for a twelve-month period ending August 23, 2012.  Under the repurchase program, the Company could purchase up to $50 million worth of its common stock.  Subsequently, the board of directors authorized the expansion of this existing stock repurchase program, effective December 5, 2011.  Under the expanded program, the Company may purchase up to an additional $39.1 million worth of its common stock, bringing the total amount authorized under the stock repurchase plan to $89.1 million through the period ending December 5, 2012.  Through December 31, 2011, the Company had repurchased 4.0 million shares of its common stock for $43.1 million.  Cash paid for repurchases of $42.8 million differs from the aggregate purchase price due to trades made at the end of the period which were settled subsequent to December 31, 2011.